Jan Stenvang

7PUBLICATIONS
19CO-AUTHORS
Molecular targetsMolecular medicinePredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|May 07, 2025
Inhibition of ABCG2 by SCO-101 Enhances Chemotherapy Efficacy in Cancer.

Anamarija Pfeiffer, Luca Di Leo, Marc Baker Bechmann

|Oct 23, 2021
Reversal of ABCG2/BCRP-Mediated Multidrug Resistance by 5,3',5'-Trihydroxy-3,6,7,4'-Tetramethoxyflavone Isolated from the Australian Desert Plant Eremophila galeata Chinnock.

Malene J Petersen, Xamuel L Lund, Susan J Semple

|Apr 03, 2021
Molecular Profiling of Docetaxel-Resistant Prostate Cancer Cells Identifies Multiple Mechanisms of Therapeutic Resistance.

Thiago S Lima, Diego Iglesias-Gato, Luciano D O Souza

|Jul 26, 2020
ABCG2 Protein Levels and Association to Response to First-Line Irinotecan-Based Therapy for Patients with Metastatic Colorectal Cancer.

Jesper Andreas Palshof, Camilla Natasha Cederbye, Estrid Vilma Solyom Høgdall

|Apr 25, 2020
An Explorative Analysis of ABCG2/TOP-1 mRNA Expression as a Biomarker Test for FOLFIRI Treatment in Stage III Colon Cancer Patients: Results from Retrospective Analyses of the PETACC-3 Trial.

Jan Stenvang, Eva Budinská, Eric van Cutsem

|Dec 08, 2019
Gel-Based Proteomics of Clinical Samples Identifies Potential Serological Biomarkers for Early Detection of Colorectal Cancer.

Stine F Thorsen, Irina Gromova, Ib J Christensen

Pageof 2

Frequent Collaborators

2 joint publications

José M A Moreira

2 joint publications

Michael Gajhede

1 joint publications

Tim Svenstrup Poulsen

1 joint publications

Dorte Linnemann